Join Wilson Sonsini and leading experts from ANYg Bio, BioOrbit, Frontier Space, ICE Cubes Service, Purdue University, Redwire Space, and SpacePharma for a virtual webinar exploring how medicine and biotechnology is being revolutionized in space and key considerations for companies in the sector.
ANYg Bio is engineering advanced biotech tools that work in any gravity to solve the problem of limited low-throughput bio-sample prep capabilities in Space. This single platform will be able to function seamlessly on Earth and in Space.
BioOrbit is aiming to be the go-to pharmaceuticals factory in microgravity, part of the space manufacturing revolution, currently developing a platform for large-scale crystallization of protein drugs.
Frontier Space is building the enabling technologies towards industrializing biotechnology in space for the benefit of life on Earth and beyond.
ICE Cubes Service by Space Applications Services is an end-to-end service launching your research and technology into space.
Purdue University is a world-renowned, public research university that advances discovers in science, technology, engineering, and math.
Redwire Space is accelerating humanity's expansion into space by delivering reliable, economical, and sustainable infrastructure for future generations.
SpacePharma is a global leader for biospace research and manufacturing of monoclonal antibodies. The company holds assets like research modules, small dose and mass production units in space. The Company granted an EIC-ACCELERATOR funding to prime the challenges of IV to SC for Europe on July 2024. SpacePharma holds patents on small molecules crystallization like monoclonal antibodies.
Adam Pilkington
apilkington@wsgr.comJohn has more than 38 years of life sciences industry experience in law, business, and science, and has worked on a wide range of deals worth a total of more than $132 billion.